Necrólisis epidérmica toxica en un paciente de 13 años
Resumen
La Necrolisis Epidermica Tóxica (NET) es una entidad cutánea debida a hipersensibilidad retardada frecuentemente ante medicamentos, y posee una incidencia de aproximadamente 1 caso por cada millón de personas. Presentamos el caso de un paciente de 13 años de edad con antecedente de síndrome convulsivo tratado con ácido valproico, el cual 15 días después del cambio de medicamento a fenitoína comienza a presentar sintomatología propia de la enfermedad. Es ingresado y el tratamiento se encuentra a cargo de pediatría, inmunología, oftalmología y cirugía plástica.
Descargas
Citas
Rojas, A., Torres, S., Salazar, V., et al (2019). Necrolisis epidérmica toxica: una patología de alta mortalidad. Revista de la Facultad de Ciencias Médicas de la Universidad Nacional de Córdoba, 76, 1-2. Recuperado de https://revistas.unc.edu.ar/index.php/med/article/view/26022
Falconí Chávez, D. S., & Jami Carrera, J. E. (2022). Síndrome de Steven-Johnson y necrolisis epidérmica toxica: revisión bibliográfica actualizada. Ciencia Latina Revista Científica Multidisciplinar, 6(5), 644-661. https://doi.org/10.37811/cl_rcm.v6i5.3105
McPherson, T., Exton, L S., Biswas, S., Creamer, D., et al (2019). British Association of Dermatologists guidelines for the management of Stevens-Johnson syndrome/toxic epidermal necrolysis in children and young people. British Journal of Dermatology, 181(1), 37-54. https://doi.org/10.1111/bjd.17841
Liotti, L., Caimmi, S., Bottau, P., et al (2019). Clinical features, outcomes and treatment in children with drug-induced Stevens-Johnson syndrome and toxic epidermal necrolysis. Acta Biomedica, 90(3), 52-60. doi:10.23750/abm.v90i3-S.8165
Frantz, R., Huang, S., Are, A., & Motaparthi, K. (2021). Stevens-Johnson syndrome and toxic epidermal necrolysis: A review of diagnosis and management. Medicina, 57(9), 895. https://doi.org/10.3390/medicina57090895
Morgado, D., Fustà, X., & Iranzo, P. (2019). FR-Ciclosporina como tratamiento de primera línea en la necrólisis epidérmicas. Actas Dermo-Sifiliográficas, 110(7), 601-603. https://doi.org/10.1016/j.ad.2018.01.014
Lerch, M., Carlo Mainetti, C., Terziroli Beretta-Piccoli, B., et al (2017). Current perspectives on Stevens-Johnson syndrome and toxic epidermal necrolysis. Clinical Reviews in Allergy & Immunology, 54, 147-176. https://doi.org/10.1007/s12016-017-8654-z
Jacobsen, A., Olabi, B., Langley, A., et al (2022). Systemic interventions for treatment of Stevens-Johnson syndrome (SJS), toxic epidermal necrolysis (TEN), and SJS/TEN overlap syndrome. Cochrane Database of Systematic Reviews, 2022(3), CD013130. https://doi.org/10.1002/14651858.CD013130.pub2
Hasegawa, A., & Abe, R. (2020). Recent advances in managing and understanding Stevens-Johnson syndrome and toxic epidermal necrolysis. Faculty Reviews, 1(2), 1-10. https://doi.org/10.12688/f1000research.24748.1
Wung, C., Wang, C., Lai, K, et al. (2023). Current understanding of genetic associations with delayed hypersensitivity reactions induced by antibiotics and anti-osteoporotic drugs. Frontiers in Pharmacology, 14(2023), 1-11. https://doi.org/10.3389/fphar.2023.1183491
Fan, W., Zhai, Q., Ma, Q., & Ge, H. (2022). Toxic epidermal necrolysis with systemic lupus erythematosus: Case report and review of the literature. Annals of Palliative Medicine, 11(6), 2144-2151. https://doi.org/10.21037/apm-21-341
Cetin, G., Sayar, H., Ozkan, F., et al (2013). A case of toxic epidermal necrolysis-like skin lesions with systemic lupus erythematosus and review of the literature. Lupus, 22(8), 839-846. https://doi.org/10.1177/0961203313492242
O’Brien, K., Maiman, R., & Marathe, K. (2019). Idiopathic toxic epidermal necrolysis in an adolescent. Pediatric Dermatology, 36(4), 550-551. https://doi.org/10.1111/pde.13820
Williams, M., & Conklin, R. (2005). Erythema multiforme: A review and contrast from Steven-Johnson syndrome/toxic epidermal necrolysis. Dental Clinics of North America, 49(1), 67-76. https://doi.org/10.1016/j.cden.2004.08.003
Surowiecka, A., Baranska, W., & Struzyna, J. (2023). Multidisciplinary treatment in toxic epidermal necrolysis. International Journal of Environmental Research and Public Health, 20(3), 2217. https://doi.org/10.3390/ijerph20032217
Houschyar, K., Tapking, C., Borrelli, M., et al (2021). Stevens-Johnson syndrome and toxic epidermal necrolysis: A 10-year experience in a burns unit. Journal of Wound Care, 30(6), 2052-2916. https://doi.org/10.12968/jowc.2021.30.6.492
Schneider, J., & Cohen, P. (2017). Stevens-Johnson syndrome and toxic epidermal necrolysis: A concise review with a comprehensive summary of therapeutic interventions emphasizing supportive measures. Advances in Therapy, 34, 1235-1244. https://doi.org/10.1007/s12325-017-0530-y
Zhang, J., Lu, C., Chen, C., et al. (2022). Evaluation of combination therapy with etanercept and systemic corticosteroids for Stevens-Johnson syndrome and toxic epidermal necrolysis: A multicenter observational study. The Journal of Allergy and Clinical Immunology: In Practice, 10(5), 1295-1304. https://doi.org/10.1016/j.jaip.2022.01.038
Yang, Y., Xu, J., Li, F., Zhu, X. (2009). Combination therapy of intravenous immunoglobulin and corticosteroid in the treatment of toxic epidermal necrolysis and Stevens-Johnson syndrome: A retrospective comparative study in China. International Journal of Dermatology, 48(10), 1122-1128. https://doi.org/10.1111/j.1365-4632.2009.04166.x
Sato, S., Kanbe, T., Tamaki, Z., Furuichi, E., et al. (2018). Clinical features of Stevens-Johnson syndrome and toxic epidermal necrolysis. Pediatrics International, 60(8), 697-702. https://doi.org/10.1111/ped.13613
Derechos de autor 2023 Marycruz Arenales Castellanos ;Andrés Ibarra Ochoa;Daniel Fernando Curuchiche Mux
Esta obra está bajo licencia internacional Creative Commons Reconocimiento 4.0.
.jpg)
